Treatment of Aortic Graft Infection in the Endovascular Era
- 345 Downloads
Purpose of Review
This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections.
Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula.
Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.
KeywordsAortic graft infection Endovascular infection Stent-graft infection Aortoenteric fistula Explantation In situ reconstruction
Compliance with Ethical Standards
Conflict of Interest
Drs Sorber, Osgood, Abularrage, Black and Lum declare that they have no conflicts of interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Oderich G, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53(1):99–106.CrossRefPubMedGoogle Scholar
- 7.• Berger P, Vaartjes I, Moll FL, De Borst GJ, Bankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg. 2015;49(5):581–5. A comprehensive overview of trends in incidence of graft infection since the advent of endovascular therapy. CrossRefPubMedGoogle Scholar
- 11.• Smeds M, Duncan AA, Harlander-Locke MP, Lawrence PF, Lyden S, Fatima J, et al. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016;63(2):332–40. Outcomes of the treatment of graft infection particularly germane to aortic endografts, highlighting new challenges of these infections and comparing outcomes to the previous experience with aortic graft infection. CrossRefPubMedGoogle Scholar
- 15.•• Hodgkiss-Harlow K, Bandyk DF. Antibiotic therapy of aortic graft infection: treatment and prevention recommendations. Semin Vasc Surg. 2011;24(4):191–8. An in-depth review of pathogens and antibiotic treatment and delivery strategies in all types of aortic graft infection. CrossRefPubMedGoogle Scholar
- 18.Sah B, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, et al., the Vasgra Cohort. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infection. Eur J Vasc Endovasc Surg. 2015;49(4):455–64.Google Scholar
- 19.Shahani L. Vascular graft infections and role of PET/CT in patients with persistent bacteraemia. BMJ Case Reports. 2015; https://doi.org/10.1136/bcr-2014-207678.
- 39.van Zitteren M, van der Steenhoven TJ, Burger DHC, van Berge Henegouwen DP, Heyligers JMM, Vriens PWHE. Spiral vein reconstruciton of the infected abdominal aorta using the greater saphenous vein: preliminary results of the Tilburg experience. Eur J Vasc Endovasc Surg. 2011;41(5):637–46.CrossRefPubMedGoogle Scholar